Clinical Research

Baseline Characteristics

Add MICARDIS® Clinical Research to My Alerts (what's this?)

Print | Send to a friend

Demography and Medical history

 

Telmisartan

(n=443)

Valsartan

(n=442)

Demography

Age (Years) 60.9 61.4
Male (%) 63.0 65.2
Body mass index (kg/m2) 30.0 30.4

Medical History

Hypertension duration (Years) 11.1 11.6
Diabetes duration (Years) 13.9 14.4
Diabetic nephropathy duration (Years) 2.7 2.8
Urinary protein excretion rate (UPER, g/24h) 2.70 2.86
Estimated glomerular filtration rate (eGFR, mL/min/1.72m2) 56.7 56.5
Smokers (%) 7.8 7.7

Blood Pressure

Systolic blood pressure (mmHg)* 147.6 148.5
Diastolic blood pressure (mmHg)* 81.6 82.4

Medications

 

Telmisartan

(n=443)

Valsartan

(n=442)

Previous Medication

Antihypertensive treatment
Beta-blockers (%) 40.9 45.7
Calcium channel blockers (%) 71.8 72.2
Diuretics (%) 63.2 70.6
Others (%) 35.2 39.1
Other medications
Oral antidiabetic agents* (%) 58.2 57.0
Insulin (%) 58.7 56.8
Statins (%) 45.1 44.6
Other lipid-lowering agents (%) 8.4 10.9
Others (%) 81.3 84.8

*Excluding metformin

References

Toolbox

Calendar

Tools and Downloads

My Alerts

You will shortly be able to create your own personal alerts service bringing the latest MICARDIS® news and updates direct to your inbox. Watch this space for more information.